Assertio Therapeutics Operating Cycle Over Time

Stocks . USA . 
Stock . Assertio Therapeutics
ASRT Stock  USD 12.74  1.12  9.64%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Assertio Therapeutics Performance and Assertio Therapeutics Correlation.
For more information on how to buy Assertio Stock please use our How to Invest in Assertio Therapeutics guide.
  
Build AI portfolio with Assertio Stock
Operating Cycle is likely to drop to 562.12 in 2026.
Is there potential for Pharmaceuticals market expansion? Will Assertio introduce new products? Factors like these will boost the valuation of Assertio Therapeutics. If investors know Assertio will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Assertio Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.19)
Earnings Share
(4.50)
Revenue Per Share
21.495
Quarterly Revenue Growth
0.694
Return On Assets
(0.04)
Understanding Assertio Therapeutics requires distinguishing between market price and book value, where the latter reflects Assertio's accounting equity. The concept of intrinsic value - what Assertio Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Assertio Therapeutics' price substantially above or below its fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Understanding that Assertio Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Assertio Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Assertio Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Specify up to 10 symbols:
Apply

Cross Equities Operating Cycle Analysis

Compare Assertio Therapeutics and related stocks such as INC Research Holdings, Nutriband, and XBiotech Operating Cycle Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AGraham Number
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
20102011201220132014201520162017201820192020202120222023202420252026
INCR64.599664.5996170228107(23.6782)349349349349335278351330495446468
NTRB19.475819.475819.475819.475819.475819.475819.475819.475819.475812.637575.414670.672582.816676.329566.341959.7146.14
XBIT34.121534.121534.121534.121534.121534.121534.121534.121534.121534.121534.121517816116116114599.29
FBIO12112112112112112112129.8718115173233238305229318286157
ACRV0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
TCRX0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
LUNG219219219219219219219219219268391517448410343309297
VXRT16724.47611999.352318727.473124.606739.381715813430.13129.052768.224314915213787.33
PMVP0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
LITS79.53379.53379.53379.53379.53379.53379.53379.53379.53379.53379.53390.08180.63550.63550.63550.730.69

Assertio Therapeutics and related stocks such as INC Research Holdings, Nutriband, and XBiotech Operating Cycle description

My Equities

My Current Equities and Potential Positions

View AllNext
Assertio Therapeutics
ASRT
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Business Address100 South Saunders
ExchangeNASDAQ Exchange
USD 12.74

Additional Tools for Assertio Stock Analysis

When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY